Global Newborn Screening Market 2018-2027: Driven by Rising Incidences of Critical Congenital Heart Defects and Government Support Towards Newborn Child Health – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)-- The "Global Newborn Screening Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Report Highlights

• The report provides a detailed analysis on current and future market trends to identify the investment opportunities
• Market forecasts till 2027, using estimated market values as the base numbers
• Key market trends across the business segments, Regions and Countries
• Key developments and strategies observed in the market
• Market Dynamics such as Drivers, Restraints, Opportunities and other trends
• In-depth company profiles of key players and upcoming prominent players
• Growth prospects among the emerging nations through 2027
• Market opportunities and recommendations for new investments

Key Topics Covered

1 Market Outline

1.1 Research Methodology

1.1.1 Research Approach & Sources

1.2 Market Trends

1.3 Regulatory Factors

1.4 Technology Analysis

1.5 Product Analysis

1.6 End User Analysis

1.7 Strategic Benchmarking

1.8 Opportunity Analysis

2 Executive Summary

3 Market Overview

3.1 Current Trends

3.1.1 Rising Incidences of Critical Congenital Heart Defects (CCHD)

3.1.2 Government Support Towards Newborn Child Health

3.1.3 Recent Technological Developments in Newborn Screening

3.1.4 Growth Opportunities/Investment Opportunities

3.2 Drivers

3.3 Constraints

3.4 Industry Attractiveness

3.4.1 Bargaining power of suppliers

3.4.2 Bargaining power of buyers

3.4.3 Threat of substitutes

3.4.4 Threat of new entrants

3.4.5 Competitive rivalry

4 Newborn Screening Market, By Test Type

4.1 Dry Blood Spot Test

4.2 Hearing Screen Test

4.3 Critical Congenital Heart Diseases (CCHD) Test

4.4 Urine Test

4.5 Other Test Types

5 Newborn Screening Market, By Technology

5.1 DNA-Based Assays

5.2 Electrophoresis

5.3 Hearing Screen Technology

5.4 Immunoassays and Enzymatic Assays

5.5 Pulse Oximetry Screening Technology

5.6 Tandem Mass Spectrometry (TMS)

6 Newborn Screening Market, By Product

6.1 Device

6.1.1 Hearing Screening Devices

6.1.2 Laparoscope

6.1.3 Mass Spectrometer

6.1.4 Pulse Oximeter

6.1.5 Retinoscope

6.1.6 Ultrasound Machine

6.2 Reagents Assay Kits

7 Newborn Screening Market, By End User

7.1 Diagnostic Centers

7.2 Hospitals

7.3 Maternity & Specialty Clinics

7.4 Ambulatory Care

7.5 Clinics

7.6 Government agencies

7.7 Nursing Homes

7.8 Local health departments

7.9 International organizations or Community organizations

8 Newborn Screening Market, By Disease Type

8.1 Biotinidase Deficiency

8.2 Blood Spot Disease

8.3 Congenital Adrenal Hyperplasia (CAH)

8.4 Congenital Hypothyroidism

8.5 Critical Congenital Cardiac Disease

8.6 Cystic Fibrosis (CF)

8.7 Hearing Disability

8.8 Maple Syrup Urine Disease (MSUD)

8.9 MCAD deficiency

8.10 Phenylketonuria (PKU)

8.11 Severe Combined immunodeficiency (SCID)

8.12 Sickle Cells Disease

8.13 Thyroid Disorder

8.14 ToxoplasmosisGalactosemia

8.15 Tyrosinemia

9 Newborn Screening Market, By Geography

9.1 North America

9.2 Europe

9.3 Asia Pacific

9.4 Middle East

9.5 Latin America

9.6 Rest of the World (RoW)

10 Key Player Activities

10.1 Mergers & Acquisitions

10.2 Partnerships, Joint Ventures, Collaborations and Agreements

10.3 Product Launch & Expansions

10.4 Other Activities

11 Leading Companies

11.1 AB Sciex

11.2 Agilent Technologies Inc.

11.3 Bio-Rad Laboratories Inc.

11.4 Covidien PLC

11.5 GE Healthcare

11.6 Masimo Corporation

11.7 Medtronic Inc.

11.8 Natus Medical Incorporated

11.9 PerkinElmer Inc.

11.10 Trivitron Healthcare

11.11 Waters Corporation

11.12 ZenTech S.A.

For more information about this report visit https://www.researchandmarkets.com/research/kcpw8g/global_newborn?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181210005331/en/

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics: Diagnostics, Maternal and Neonatal Care

Source: Research and Markets